Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 225,967 |
|
|||||
| News | - | ||||||
| Day High | 34.305 | Low High |
|||||
| Day Low | 32.07 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spyre Therapeutics Inc | SYRE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.09 | 3.36% | 33.56 | 18:49:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 32.63 | 32.07 | 34.305 | 33.56 | 32.47 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,298 | 225,967 | $ 33.57 | $ 7,586,553 | - | 10.42 - 47.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:26:30 | 2 | $ 30.24 | USD |
Spyre Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.21B | 36.15M | - | 886k | -338.79M | -9.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spyre Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SYRE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 34.10 | 35.88 | 31.27 | 32.98 | 259,225 | -0.54 | -1.58% |
| 1 Month | 37.82 | 40.835 | 31.27 | 35.53 | 318,240 | -4.26 | -11.26% |
| 3 Months | 25.63 | 47.97 | 20.07 | 33.62 | 512,486 | 7.93 | 30.94% |
| 6 Months | 10.81 | 47.97 | 10.42 | 30.76 | 384,892 | 22.75 | 210.45% |
| 1 Year | 10.81 | 47.97 | 10.42 | 30.76 | 384,892 | 22.75 | 210.45% |
| 3 Years | 10.81 | 47.97 | 10.42 | 30.76 | 384,892 | 22.75 | 210.45% |
| 5 Years | 10.81 | 47.97 | 10.42 | 30.76 | 384,892 | 22.75 | 210.45% |
Spyre Therapeutics Description
| Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. |
